Cargando…
Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
Background: Thyrotropin secreting pituitary adenomas (TSH-oma) account for less than 1% of pituitary adenomas and are a rare cause of hyperthyroidism. In this case, we describe the safe use of cabergoline with the subsequent achievement of euthyroid levels and the resolution of symptoms. Clinical Ca...
Autores principales: | Saand, Aisha R, Flores, Monica, Alqaisi, Sura, Lashin, Ossama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266158/ http://dx.doi.org/10.1210/jendso/bvab048.1977 |
Ejemplares similares
-
MON-LB100 Worse Clinical Characteristics and More Unsatisfactory Therapeutic Outcomes in Coexisting Thyrotropin Pituitary Adenomas
por: Han, Huiqiao, et al.
Publicado: (2019) -
FRI476 Asymptomatic Thyrotropin-secreting Pituitary Microadenoma With Biochemical Secondary Hyperthyroidism: A Diagnostic Conundrum
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023) -
A Case of TSH-Secreting Pituitary Adenoma With Unusual Positive Staining for SF1
por: Robinson, Kathleen, et al.
Publicado: (2021) -
LBODP100 A Rare Case Of Pembrolizumab Induced Graves’ Disease
por: Alqaisi, Sura, et al.
Publicado: (2022) -
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
por: Fang, Hong-Juan, et al.
Publicado: (2017)